Search - tctmd.com

Displaying 821 - 840 of 3148

Sort: Relevancy | Date

News Daily News

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Caitlin E. Cox

April 15, 2022

News Conference News ACC 2022

Managing AF Patients Undergoing PCI—Some Lingering Questions

Michael O'Riordan

April 12, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for April Week 2

Todd Neale

April 11, 2022

News Conference News ACC 2022

QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis

L.A. McKeown

April 07, 2022

News Conference News ACC 2022

Most Infected Cardiac Implanted Electronic Devices Not Removed Fast Enough

Michael O'Riordan

April 04, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

L.A. McKeown

March 29, 2022

News Daily News

Early Aspirin Tied to Less In-Hospital Mortality in Moderate COVID-19

Todd Neale

March 25, 2022

News Daily News

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

L.A. McKeown

March 22, 2022

News Daily News

No Stents in STEMI? With Careful Selection, Maybe

Caitlin E. Cox

March 21, 2022

News Daily News

Diet Drinks May Help With Weight Loss and Cardiometabolic Control

L.A. McKeown

March 17, 2022

News Daily News

Subcutaneous ICD Has Favorable Outcomes in Older Patients

Todd Neale

March 15, 2022

News Daily News

Guideline-Directed Therapies Underused in Frail HF Patients

L.A. McKeown

March 11, 2022

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

News Daily News

Strength Training Linked to Less Premature Mortality, CVD, and Diabetes

Michael O'Riordan

March 02, 2022

News Daily News

GRACE Performs Poorly in Ethnic Minorities With NSTEMI, Study Finds

L.A. McKeown

March 01, 2022

News Daily News

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

Yael L. Maxwell

March 01, 2022

News Daily News

Financial Strain Ups Risk of Death After Acute MI in the Elderly

L.A. McKeown

February 25, 2022

News Daily News

FDA Approves Empagliflozin for Treatment of HFpEF

Michael O'Riordan

February 24, 2022

Advertisement

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Managing AF Patients Undergoing PCI—Some Lingering Questions

COVID-19: TCTMD’s Dispatch for April Week 2

QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis

Most Infected Cardiac Implanted Electronic Devices Not Removed Fast Enough

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

PAD Significantly Ups Morbidity and Mortality in AMICS

Early Aspirin Tied to Less In-Hospital Mortality in Moderate COVID-19

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

No Stents in STEMI? With Careful Selection, Maybe

Diet Drinks May Help With Weight Loss and Cardiometabolic Control

Subcutaneous ICD Has Favorable Outcomes in Older Patients

Guideline-Directed Therapies Underused in Frail HF Patients

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Strength Training Linked to Less Premature Mortality, CVD, and Diabetes

GRACE Performs Poorly in Ethnic Minorities With NSTEMI, Study Finds

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

Financial Strain Ups Risk of Death After Acute MI in the Elderly

FDA Approves Empagliflozin for Treatment of HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content